ClinicalTrials.gov
public full text
Public Domain
Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease
Vitamin E's potential in treating non-alcoholic fatty liver disease (NAFLD) is attributed to its antioxidant properties. While tocopherols have shown significant results in NAFLD management, the powerful properties of tocotrienols, another form of saturated vitamin E, remain understudied. This research aims to assess tocotrienol's effectiveness in treating NAFLD, expanding our understanding of its therapeutic benefits.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of the Consumption of Broccoli Sprouts in Overweight Subjects#899358
- Polymorphism C677T MTHFR and Folate Intake in Inflammatory Biomarkers#865766
- Allicin Bioavailability From Garlic Supplements and Garlic Foods#1126650
- An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease#1170460
- Antinutrientes e atividade antioxidante da farinha de subprodutos do mamão#1017090
Record · ID 1140813
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive